Galapagos | Kostnadene For Salg

Cost Of Sales Endring Dato
AstraZeneca USD 2.06B 91M 2023-09
Gilead Sciences USD 1.61B 46M 2023-12
GRIFOLS EUR 1.08B 114.07M 2023-12
Hikma Pharmaceutical USD 694M 32M 2023-06
Roche Holding CHF 7.62B 1.33B 2023-06
UCB EUR 802M 27M 2023-06
Vertex Pharmaceuticals USD 318.7M 10.1M 2023-09



Galapagos Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.